T3D Therapeutics t3dtherapeutics.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

T3D Therapeutics is a privately-held pharmaceutical R&D company developing and commercializing T3D-959, potentially an optimal disease remedial therapeutic for the treatment of Alzheimer's Disease. Unlike single dimension therapies in development that target one abnormality (i.e. pathology), for example beta amyloid plaques or tau bundles, this oral once-a-day therapy acts in a multidimensional manner. As a dual nuclear receptor agonist, T3D-959 may regulate a myriad of genes involved in Alzheim...Show all

T3D Therapeutics is a privately-held pharmaceutical R&D company developing and commercializing T3D-959, potentially an optimal disease remedial therapeutic for the treatment of Alzheimer's Disease. Unlike single dimension therapies in development tha...Show all

Company (Alive / Active)

Phone: 919-949-0517

Fax:

68 TW Alexander Drive

Durham, 27709
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
T3D Therapeutics $18M May 21, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related T3D Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of treating liver disease using indane acetic acid derivatives Mar 23, 2016 Application